(+)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride

(+)-[3-cyano-3-(3,4-dimethoxyphenyl)hex-6-yl](5,6-dimethoxyphenethyl)methylammonium chloride

38176-02-2

C27H41ClN2O5; C27H38N2O4.ClH

R(+)-VERAPAMIL MONOHYDROCHLORIDE MONOHYDRATE; Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-, monohydrochloride, (aR)- (9CI); Benzeneacetonitrile, a-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-a-(1-methylethyl)-, monohydrochloride, (R)-; Dexverapamil monohydrochloride; LU 33925; NSC 632821; Benzeneacetonitrile, alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (alphaR)-; Benzeneacetonitrile, alpha-[3-[[2-(3,4-dimethoxyphenyl)ethyl]-methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (R)-;EINECS 253-810-3; UNII-B0P742MK5O; Systematic Name (+)-(3-Cyano-3-(3,4-dimethoxyphenyl)hex-6-yl)(5,6-dimethoxyphenethyl)methylammonium chloride; Registry Numbers CAS Registry Number 38176-02-2;FDA UNII B0P742MK5O;System Generated Number 0038176022; Molecular Formulas ?Molecular Formula C27-H38-N2-O4.Cl-H;Molecular Formula Fragments C27-H38-N2-O4; Cl-H; COMPONENT;

509.08

253-810-3

c1(cc(c(cc1)OC)OC)[C@](C#N)(C(C)C)CCC[N@@](C)CCc1cc(c(cc1)OC)OC.Cl

DOQPXTMNIUCOSY-HZPIKELBSA-N

1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H/t27-;/m1./s1